CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 129 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,000 | -88.3% | 12,195 | -62.0% | 0.00% | – |
| Q2 2023 | $170,250 | 0.0% | 32,062 | 0.0% | 0.00% | – |
| Q1 2023 | $170,250 | -55.8% | 32,062 | -47.7% | 0.00% | – |
| Q4 2022 | $385,353 | -99.9% | 61,362 | +2.2% | 0.00% | – |
| Q3 2022 | $633,675,000 | +88.2% | 60,064 | -3.2% | 0.00% | – |
| Q2 2022 | $336,758,000 | +21.1% | 62,018 | +104.7% | 0.00% | – |
| Q1 2022 | $278,154,000 | – | 30,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |